Insulet
PODD · NASDAQ
$142.64+$0.68 (+0.48%)TodayMarket closed ·
Prev close $141.96
EPS: actual vs estimate
Beat the estimate in 8 of the last 8 quarters, by 14.2% on average
Next report: , before the market opens
- Quarter
- Q3 FY26
- EPS estimate
- $1.59
- Revenue estimate
- $832.77M
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $1.48 | $1.66 | +12.2% |
| Q1 FY26 | $1.22 | $1.42 | +16.2% |
| Q4 FY25 | $1.48 | $1.55 | +4.5% |
| Q3 FY25 | $1.16 | $1.24 | +6.5% |
| Q2 FY25 | $0.9458 | $1.17 | +23.7% |
| Q1 FY25 | $0.8112 | $1.01 | +24.5% |
| Q4 FY24 | $1.05 | $1.15 | +10.0% |
| Q3 FY24 | $0.7768 | $0.90 | +15.9% |
Earnings calls
- Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum
- Wells Fargo 21st Annual Healthcare Conference
- PODD - Earnings call Q2 2026
- Special Call - Insulet Corporation
- 46th Annual William Blair Growth Stock Conference
- Bank of America Global Healthcare Conference 2026
- PODD - Earnings call Q1 2026
- Special Call - Insulet Corporation
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.